Pasgala, Ronie, JR.. S.
HRN: 15-17-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CEFTRIAXONE 1G (VIAL)
08/30/2023
09/06/2023
IV
500mg
Q12
Mastoiditis, Left
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes